Cargando…
In silico panning for a non-competitive peptide inhibitor
BACKGROUND: Peptide ligands have tremendous therapeutic potential as efficacious drugs. Currently, more than 40 peptides are available in the market for a drug. However, since costly and time-consuming synthesis procedures represent a problem for high-throughput screening, novel procedures to reduce...
Autores principales: | Yagi, Yukiko, Terada, Kotaro, Noma, Takahisa, Ikebukuro, Kazunori, Sode, Koji |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781467/ https://www.ncbi.nlm.nih.gov/pubmed/17222344 http://dx.doi.org/10.1186/1471-2105-8-11 |
Ejemplares similares
-
Peptide ligand screening of α-synuclein aggregation modulators by in silico panning
por: Abe, Koichi, et al.
Publicado: (2007) -
Screening of Peptide Ligands for Pyrroloquinoline Quinone Glucose Dehydrogenase Using Antagonistic Template-Based Biopanning
por: Abe, Koichi, et al.
Publicado: (2013) -
Partial Peptide of α-Synuclein Modified with Small-Molecule Inhibitors Specifically Inhibits Amyloid Fibrillation of α-Synuclein
por: Yoshida, Wataru, et al.
Publicado: (2013) -
Artificial complementary chromatic acclimation gene expression system in Escherichia coli
por: Ariyanti, Dwi, et al.
Publicado: (2021) -
Aptameric enzyme subunit for homogeneous DNA sensing
por: Ikebukuro, Kazunori, et al.
Publicado: (2007)